Opus Genetics, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $45.1M | $30.3M | $50.5M | $42.6M | $24.5M | $16.4M | $1.5M | $8.7M |
| Accounts Receivable | $2.0M | $3.6M | $926.0K | $1.3M | $0 | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $50.0M | $36.6M | $53.9M | $49.0M | $26.1M | $17.7M | $1.8M | $15.9M |
| Property, Plant & Equipment | $199.0K | $252.0K | $0 | $6.0K | $10.0K | $14.0K | $22.0K | $112.5K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $50.2M | $36.9M | $53.9M | $49.0M | $26.1M | $17.7M | $1.8M | $16.0M |
| Liabilities | ||||||||
| Accounts Payable | $3.3M | $3.1M | $2.2M | $1.1M | $1.6M | $1.2M | $342.0K | — |
| Total Current Liabilities | $7.8M | $11.3M | $4.0M | $2.8M | $3.9M | $3.2M | $9.3M | $3.2M |
| Long-Term Debt | $1.1M | $0 | — | — | — | — | — | — |
| Total Liabilities | $34.9M | $11.3M | $4.0M | $2.8M | $3.9M | $31.1M | $9.3M | $5.5M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-188.6M | $-139.0M | $-81.5M | $-71.5M | $-89.4M | $-32.7M | $-8.1M | $-154.7M |
| Total Stockholders' Equity | $15.3M | $6.7M | $49.9M | $46.2M | $22.2M | $-13.5M | $-7.6M | $-1.7M |